Startups
Edit
Tvardi Therapeutics
http://www.tvardi.com/Last activity: 23.06.2021
Active - Reference to Tvardi
Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists and dedicated physicians.
Tvardi is focused on the development of inhibitors of STAT3, a key signaling molecule positioned at the intersection of many pathways controlling gene networks integral to the survival and immune sequestration of cancer cells as well as to the pathogenesis of many inflammatory and fibrotic conditions.
Tvardi is conducting a first-in-human Phase Ia dose-escalating study to determine safety and dosing for follow-on studies for its lead compound, TTI-101.
Collectively, the societal and economic impact of STAT3-dependent disease is significant. Tvardi is highly motivated to develop safe and effective small molecule inhibitors of STAT3 for use across numerous diseases.
Tvardi is focused on the development of inhibitors of STAT3, a key signaling molecule positioned at the intersection of many pathways controlling gene networks integral to the survival and immune sequestration of cancer cells as well as to the pathogenesis of many inflammatory and fibrotic conditions.
Tvardi is conducting a first-in-human Phase Ia dose-escalating study to determine safety and dosing for follow-on studies for its lead compound, TTI-101.
Collectively, the societal and economic impact of STAT3-dependent disease is significant. Tvardi is highly motivated to develop safe and effective small molecule inhibitors of STAT3 for use across numerous diseases.
Overview
Location
United States, Texas, Houston
Employees
1-10
Total raised
$79M
Founded date
2017
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jul 26, 2020 | Grant | $5M |
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 13, 2021 | To expand or not to expand? Houston researcher weighs in on global growth | You built your business from the ground up, patiently finding techniques and products that work, carefully crafting solid bonds with your clients. Then one day a new project, opportunity or simple request poses a question: Is it time to bra... |
| May 11, 2021 | Global accelerator announces 5 startups to its Houston cohort | Five Houston companies have been tapped to participate in a Houston-based, early-stage startup accelerator with a national presence. The accelerator, gBETA, selected the five Houston companies out of over 85 applicants. The cohort represent... |
| May 10, 2021 | Energy giant makes Houston sole headquarters in massive move | Power player NRG Energy is laser focused on Houston. The Bayou City will be the energy giant's new sole headquarters; the company will no longer split between Houston and Princeton, New Jersey. The move to a single headquarters simplifies b... |
| Mar 5, 2021 | Photos: Here's a sneak peek at The Ion Houston's construction progress | The Ion Houston is expected to open its doors this year, and the building's exterior is close to completion. Now, the construction team is focusing on interiors and then tenant build outs. The 270,000-square-foot coworking and innovation hu... |
| Jan 27, 2021 | Rice University competition to link veterans with NextSeed investors | Rice University's Business Veterans Association has helped military veteran raise more that $3.5 million in investments over the last seven years through it's annual pitch competition. And this year, the stakes are even higher. The Veterans... |
| Dec 28, 2020 | Editor's Picks: Top 10 Houston startup feature stories of the year | Editor's note: As 2020 comes to a close, InnovationMap is looking back at the year's top stories in Houston innovation. This past year, InnovationMap featured profiles on dozens of these Houston startups — from blockchain and software compa... |
| Dec 22, 2020 | Here are the top 5 Houston startup venture capital deals in 2020 | Editor's note: As 2020 comes to a close, InnovationMap is looking back at the year's top stories in Houston innovation. When it came to the money raised in Houston, these five startups raised the most, according to reporting done by Innovat... |
| Nov 16, 2020 | Houston organization names 10 most promising life sciences startups | Last week, the Rice Alliance for Technology and Entrepreneurship gathered over 1,000 life science experts and attendees virtually for thought leadership as well as 40 company presentations. The three-day 2020 Virtual Texas Life Science Foru... |
| Aug 4, 2020 | Houston tech companies have raised over $466M so far this year, new report finds | This year might be a wash for a lot of things, but according to a new fundraising report from Houston Exponential, the Bayou City has seen an increase in funding this year compared to 2019. The HTX Funding Review found that Houston startups... |
Show more
Reviews 0
FAQ about Tvardi Therapeutics
When was Tvardi Therapeutics founded?
Tvardi Therapeutics was founded in 2017.
How much funding has Tvardi Therapeutics raised?
Tvardi Therapeutics has raised $79M in total across 2 funding rounds.
What funding rounds has Tvardi Therapeutics raised?
Parsers VC lists 2 funding rounds of Tvardi Therapeutics, among them a grant of $5M on Jul 26, 2020.
What has the press written about Tvardi Therapeutics?
Parsers VC has collected 12 articles mentioning Tvardi Therapeutics, among them “To expand or not to expand? Houston researcher weighs in on global growth” (May 13, 2021) and “Global accelerator announces 5 startups to its Houston cohort” (May 11, 2021).
Is Tvardi Therapeutics still active?
Yes, Tvardi Therapeutics is active; its latest activity on Parsers VC dates from Jun 23, 2021.